Investment
Features
FeesSafety
Academy
More
Pluang+

Morgan Stanley Direct Lending faces earnings pressure and dividend risk despite high yield and discount.

Analyst Insights
15 Sep 2026
Seeking Alpha
View Source
Bearish
Morgan Stanley Direct Lending faces earnings pressure and dividend risk despite high yield and discount.

Morgan Stanley Direct Lending (MSDL) currently trades at a 0.75x price to net asset value (P/NAV) and offers a yield above 12%, attracting income-focused investors. However, the business development company (BDC) is experiencing challenges including a decline in net investment income to $0.45 in Q2, a shrinking portfolio, and rising non-accrual loans at 2.9%. These factors have led to a declining NAV and tight dividend coverage, signaling deteriorating credit quality and increasing the risk of another dividend cut. The author maintains a hold rating on MSDL, citing that downside risks outweigh potential gains until the recent joint venture can deliver meaningful earnings growth.

Morgan Stanley Direct Lending trades at 0.75x price to net asset value and offers a yield above 12%, providing a notable income opportunity. For readers following financial stocks, here is Pluang's market snapshot as of Sep 15, 2026 17:41 WIB: out of 74 priced Financials-sector US stocks, 17 rose and 50 fell today. Notable movers include BBVA at USD 28.54 (-1.92%), Prudential PLC at USD 26.16 (-1.80%), and T Rowe Price Group Inc at USD 104.20 (-1.51%).

More News

Hormel Foods price target cut to $23 amid hopes for valuation rebound despite 50% share drop.

Hormel Foods price target cut to $23 amid hopes for valuation rebound despite 50% share drop.

BNP Paribas lowered Hormel Foods' price target from $26 to $23, indicating a potential 16.2% upside from its current price of around $19.80. Despite a 50.5% decline in its share price over five years, Hormel Foods remains attractive for dividend inve...

Analyst Insights
Neutral
1 hour ago
Barclays rates Becton Dickinson 'Underweight' amid $3B U.S. manufacturing partnership

Barclays rates Becton Dickinson 'Underweight' amid $3B U.S. manufacturing partnership

Barclays initiated coverage of Becton, Dickinson and Company (BDX) with an "Underweight" rating, indicating a cautious outlook for the medical technology stock. BDX is partnering with the U.S. government to boost domestic manufacturing and strengthen...

Market News
Bearish
1 hour ago
Morgan Stanley raises Eli Lilly price target to $1,430, signaling 20.8% potential upside.

Morgan Stanley raises Eli Lilly price target to $1,430, signaling 20.8% potential upside.

Morgan Stanley increased its price target for Eli Lilly to $1,430 from $1,419, maintaining an Overweight rating. This new target implies a potential upside of about 20.8% from the current share price of around $1,184. The adjustment reflects updated ...

Analyst Insights
Bullish
2 hours ago
Arthur J. Gallagher sees 6% organic growth; analysts split on price targets amid mixed outlook.

Arthur J. Gallagher sees 6% organic growth; analysts split on price targets amid mixed outlook.

Arthur J. Gallagher expects about 6% organic growth in Q3, driven by strong client retention and new business despite easing property insurance pricing. Cantor Fitzgerald lowered its price target to $280, below the $288 average from 19 analysts who m...

Analyst Insights
Bullish
3 hours ago
Zscaler's price target raised to $255 on strong AI-driven cybersecurity demand and growth outlook.

Zscaler's price target raised to $255 on strong AI-driven cybersecurity demand and growth outlook.

Needham raised Zscaler's price target to $255, citing strong demand for AI-related cybersecurity solutions. Zscaler aims to exceed $8 billion in annual recurring revenue by fiscal 2031, driven by increasing needs to protect against AI-powered cyberat...

Analyst Insights
Bullish
3 hours ago
banner-footerbanner-footer

Invest & Trade with
#1 Award-Winning Investment Super App